RheumaFinder Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Seed

  • Investors
  • 1

RheumaFinder General Information

Description

Developer of a medical imaging platform designed to detect rheumatic diseases. The company's platform utilizes artificial technology to analyse standard medical images to detect early signs of joint damage, addressing diagnostic delays and underdiagnosis in rheumatic diseases to support timely clinical decision making, enabling healthcare practitioners to provide timely interventions for patients.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Vlasgaardstraat 52
  • 9000 Ghent
  • Belgium
Primary Industry
Decision/Risk Analysis
Other Industries
Other Healthcare Technology Systems
Corporate Office
  • Vlasgaardstraat 52
  • 9000 Ghent
  • Belgium

RheumaFinder Timeline

202420252026
Date FoundedFinancing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

RheumaFinder Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Seed Round 12-Aug-2025 Completed Product In Beta Test
1. Seed Round 29-Dec-2023 Completed Product Development
To view RheumaFinder’s complete valuation and funding history, request access »

RheumaFinder Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed
To view RheumaFinder’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

RheumaFinder Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

RheumaFinder Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Novalis Biotech Venture Capital Minority
To view RheumaFinder’s complete investors history, request access »

RheumaFinder FAQs

  • When was RheumaFinder founded?

    RheumaFinder was founded in 2023.

  • Where is RheumaFinder headquartered?

    RheumaFinder is headquartered in Ghent, Belgium.

  • What is the size of RheumaFinder?

    RheumaFinder has 10 total employees.

  • What industry is RheumaFinder in?

    RheumaFinder’s primary industry is Decision/Risk Analysis.

  • Is RheumaFinder a private or public company?

    RheumaFinder is a Private company.

  • What is RheumaFinder’s current revenue?

    The current revenue for RheumaFinder is .

  • How much funding has RheumaFinder raised over time?

    RheumaFinder has raised $300K.

  • Who are RheumaFinder’s investors?

    Novalis Biotech has invested in RheumaFinder.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process